The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalen, Izan, Cobo, María Mercedes, Gutierrez, Bernardo, Carrazco-Montalvo, Andrés, Ponce, Patricio, Cisneros-Heredia, Diego F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951684/
https://www.ncbi.nlm.nih.gov/pubmed/35330076
http://dx.doi.org/10.3390/life12030325
Descripción
Sumario:The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

Ejemplares similares